Physician profile
Jesse Blake Kellum
NPI 1194735738
$10,233.07
in general payments reported to CMS, 2019-2025
71 companies · $1,288 in 2025
The $1,288 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,378 · 2020: $746 · 2021: $1,763 · 2022: $1,259 · 2023: $1,721 · 2024: $2,077 · 2025: $1,288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,050 · Education: $35.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,050.15 |
| Education | $35.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,211.77 | 2019-2025 | |
| Emd Serono, INC. | $624.44 | 2019-2025 | Mavenclad, Mavenclad |
| Ucb, INC. | $613.33 | 2019-2025 | Briviact, Fintepla |
| Novartis Pharmaceuticals Corporation | $596.74 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $431.94 | 2019-2025 | Ultomiris, Strensiq |
| Acadia Pharmaceuticals INC | $418.42 | 2019-2025 | Nuplazid, Daybue |
| Ani Pharmaceuticals, INC. | $365.77 | 2022-2023 | Purified Cortrophin Gel |
| Genzyme Corporation | $340.39 | 2019-2023 | |
| Biohaven Pharmaceuticals, INC. | $311.08 | 2021 | |
| Genentech USA, INC. | $294.96 | 2019-2025 | Ocrevus Zunovo, Ocrevus |
| Lundbeck LLC | $267.66 | 2019-2024 | Vyepti |
| Lilly USA, LLC | $265.20 | 2019-2025 | Kisunla, Amyvid, Zepbound |
| Amgen INC. | $258.11 | 2019-2024 | Aimovig, Repatha |
| Neurocrine Biosciences, INC. | $254.36 | 2021-2025 | Ingrezza, Ongentys |
| Sk Life Science, INC. | $240.50 | 2021-2025 | Xcopri |
Show all 71 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Kellum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.